Fred Alger Management’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-15,138
Closed -$2.22M 552
2022
Q4
$2.22M Buy
15,138
+182
+1% +$26.7K 0.01% 332
2022
Q3
$2.53M Sell
14,956
-3,030
-17% -$512K 0.01% 318
2022
Q2
$2.08M Buy
17,986
+5,063
+39% +$585K 0.01% 332
2022
Q1
$1.29M Buy
12,923
+3,783
+41% +$377K ﹤0.01% 368
2021
Q4
$1.42M Buy
+9,140
New +$1.42M ﹤0.01% 377